Prot# DORI-10: A Multicenter, Randomized, Open-Label Phase 3 Study to Compare the Safety and Efficacy of Intravenous Doripenem with that of Intravenous Imipenem in Ventilator-Associated Pneumonia

Project: Research project

Project Details

StatusFinished
Effective start/end date5/5/055/9/07

Funding

  • US Micron (DORI-10)
  • Peninsula Pharmaceuticals, Inc. (DORI-10)